InstalabSterols Panel
Should you take a Sterols Panel test?
This test is most useful if any of these apply to you.
9 Biomarkers Included
- CampesterolThe other main absorption marker; when high relative to synthesis markers, it points to an absorber pattern that may respond better to absorption-blocking therapy.High campesterol relative to synthesis markers suggests you rely more on absorbing cholesterol than making it.
- DesmosterolA second synthesis marker that rises and falls with lathosterol, confirming how active your internal cholesterol production is.High desmosterol alongside high lathosterol confirms a synthesizer pattern of cholesterol metabolism.
- LathosterolA direct precursor in cholesterol production; higher levels mean your body makes more of its own cholesterol.Low lathosterol has been linked in some cohorts to higher cardiovascular and overall mortality.
- Beta-SitosterolA plant sterol absorbed alongside cholesterol; higher levels suggest gut absorption drives your cholesterol, and very high levels can flag a rare inherited condition.Markedly high beta-sitosterol can indicate sitosterolemia, a rare genetic disorder often mistaken for familial high cholesterol.
- Beta-Sitosterol (Normalized)Beta-sitosterol divided by total cholesterol, correcting for carrier particle differences so absorption can be compared fairly across people.The normalized value is the more comparable way to judge whether your absorption is genuinely high.
- Campesterol (Normalized)Campesterol relative to total cholesterol, the form used in most research to place you on the absorber side of the balance.A high normalized campesterol is a cleaner signal of an absorption-dominant phenotype.
- Desmosterol (Normalized)Desmosterol relative to total cholesterol, adjusting for carrier particles so your synthesis signal is not distorted by overall cholesterol level.Normalized desmosterol helps confirm synthesis dominance independent of your total cholesterol.
- Lathosterol (Normalized)Lathosterol relative to total cholesterol, the standard way synthesis is reported; it is the noisiest marker and needs larger changes to interpret.Because lathosterol varies day to day, only sizable shifts in the normalized value are meaningful.
- Cholesterol Balance ScoreA single ratio combining synthesis and absorption markers to summarize which side dominates your cholesterol metabolism.It converts separate sterol values into one absorber-versus-synthesizer readout that no single marker provides.
About Sterols Panel
Two people can have the exact same LDL number and arrive there in completely different ways. One absorbs extra cholesterol from food through the gut. The other manufactures extra cholesterol in the liver. A standard cholesterol test cannot tell these two people apart.
This panel is built to separate them. It measures the molecular traces your body leaves when it absorbs cholesterol versus when it builds its own, then combines them into a single balance picture. That picture is an emerging way to understand why your cholesterol behaves as it does, though standardized interpretation is still being worked out.
What This Panel Reveals
Your body keeps its cholesterol supply steady using two levers: pulling cholesterol in from the intestine, and producing it internally. This panel reads both levers at once. That is something total cholesterol and LDL cannot do, because those numbers show the final amount in your blood, not where it came from.
The absorption side is tracked by two plant-derived sterols, campesterol and beta-sitosterol. You cannot make these molecules yourself, so when they show up in your blood in higher amounts, it means your gut is efficiently absorbing sterols, cholesterol included. This marks you toward an absorber pattern.
The synthesis side is tracked by lathosterol and desmosterol, two molecules that appear as stepping stones while your body assembles cholesterol. Higher levels mean your internal cholesterol factory is running hot. Because these two tend to rise and fall together, seeing both elevated is a stronger signal than either one alone.
Each marker also appears in a normalized form, meaning it is divided by your total cholesterol. Sterols travel through the blood on the same carrier particles as cholesterol, so the normalized value corrects for how many carriers you happen to have and lets your result be compared fairly against other people. The Cholesterol Balance Score then rolls synthesis and absorption together into one number that names which side dominates.
How to Read Your Results Together
In healthy people, absorption and synthesis usually move in opposite directions. When the gut brings in more cholesterol, the liver dials back its own production, and the reverse holds too. Because of this seesaw, any single marker means much more when you can see what the opposite lever is doing.
| Your Pattern | Likely Phenotype | What It Suggests |
|---|---|---|
| High campesterol and beta-sitosterol, low lathosterol and desmosterol | Absorber | Gut absorption is the main driver. Approaches that block cholesterol absorption may be a logical fit, though the evidence that phenotype predicts drug response is not settled. |
| Low absorption markers, high lathosterol and desmosterol | Synthesizer | Your liver makes most of your cholesterol. This is the pathway statins are designed to slow. |
| Both absorption and synthesis markers high | Mixed or dysregulated | The normal feedback balance may be impaired, which makes the markers harder to interpret cleanly. |
| Very high beta-sitosterol and campesterol | Possible rare disorder | Consider sitosterolemia, a rare inherited condition often mistaken for genetic high cholesterol. |
One caution shapes how strongly you should read these patterns. In several large cohorts, higher absorption markers and lower synthesis markers tracked with more cardiovascular disease (disease of the heart and blood vessels), yet a meta-analysis pooling 17 studies and 11,182 people found no consistent link between circulating campesterol or beta-sitosterol and cardiovascular risk. The signal is real in some populations and absent in others, so treat the pattern as informative context, not a verdict.
What to Do with Your Results
If your absorption markers dominate and your LDL is stubborn, that is worth discussing with a clinician who manages lipids, because absorber patterns are the setting where an absorption-blocking medication is most mechanistically sensible, even though trials have not consistently shown that baseline sterol phenotype predicts who responds best. If synthesis markers dominate, the internal production pathway is the target. In both cases, pair this panel with the particle-focused tests that predict risk most directly, such as ApoB (apolipoprotein B, a direct count of your cholesterol-carrying particles) and lipoprotein(a).
A very high beta-sitosterol result deserves separate attention. Sitosterolemia is diagnosed at a serum sitosterol at or above 10 micrograms per milliliter, far above the roughly 1 to 4.5 micrograms per milliliter seen in healthy adults, and confirmed cases often run 30 to 100 times normal. If your value is in that territory, ask about genetic testing of the ABCG5 and ABCG8 genes.
For tracking over time, keep the interval sensible. These markers carry real day-to-day biological noise, so a repeat is most useful after a diet or medication change has settled, done fasting, in the morning, at the same laboratory. Retesting once or twice a year is reasonable for someone actively managing lipids.
When Results Can Be Misleading
Medications shift the whole panel. Statins lower synthesis markers and can raise absorption markers as the body compensates, while absorption-blocking drugs do the opposite. If you already take a lipid medication, your pattern reflects the drug as much as your underlying biology.
Diet and lab technique matter too. Foods and supplements enriched with plant sterols push absorption markers up on their own, and results from different laboratories do not always agree even with shared calibration. Lathosterol is the noisiest marker of the group, and its reliability as a synthesis stand-in has even been questioned under some drug treatments, so only sizable changes, on the order of 30 percent or more, are worth acting on. Reading the markers together, in context, is far more reliable than reacting to one value in isolation.